Fixsen Dean L
Active Implementation Research Network, Inc., Albuquerque, NM, United States.
Front Health Serv. 2025 Apr 25;5:1575179. doi: 10.3389/frhs.2025.1575179. eCollection 2025.
Fidelity is not yet a requirement when developing an evidence-based innovation or when attempting to use an innovation in typical settings. Currently, users are encouraged to adapt innovations to fit existing practitioner skills and organization situations. Instead of adapting innovations, the essential components of an innovation need to be established in the original research and the essential components need to be used in practice with the support of implementation processes so that promised outcomes can be realized. Fidelity is an assessment of the presence and strength of the essential components that define the independent variable (the innovation) and is directly linked to outcomes. A test of any fidelity assessment is a high correlation (0.70+) with outcomes. The functional relationship between fidelity and outcomes ensures that the essential components are effective and ensures that a reliable fidelity assessment is available. Implementation is the planned process of putting something into effect. Evidence that an innovation has been put into effect is provided by the fidelity assessment. High fidelity scores indicate that the essential components of the innovation are in place and good outcomes are expected. A test of any planned process is fidelity of the use of the innovation. At present fidelity assessments are missing or inadequate and, therefore, there is a notable lack of evidence that an independent variable is present.
在开发基于证据的创新或尝试在典型环境中应用创新时,保真度尚未成为一项要求。目前,鼓励用户对创新进行调整,以适应现有的从业者技能和组织情况。创新的关键组成部分不应进行调整,而应在原始研究中确定,并在实施过程的支持下在实践中加以运用,以便实现预期的成果。保真度是对定义自变量(创新)的关键组成部分的存在和强度的评估,并且与结果直接相关。任何保真度评估的检验标准是与结果具有高度相关性(0.70以上)。保真度与结果之间的功能关系确保了关键组成部分是有效的,并确保有可靠的保真度评估。实施是使某事生效的计划过程。保真度评估提供了创新已生效的证据。高保真度分数表明创新的关键组成部分已到位,并且预期会有良好的结果。对任何计划过程的检验都是创新使用的保真度。目前,保真度评估缺失或不充分,因此,明显缺乏自变量存在的证据。